Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss from operations	$ (3,256,366)	$ (4,150,352)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	11,248	9,831
Stock-based compensation expense	8,940
Changes in assets and liabilities:
Insurance claim receivable	200,000	324,030
Prepaid expenses and other current assets	1,238,994	1,007,152
Other assets	9,133
Amortization of right-of-use asset	135,141	136,861
Accounts payable	(567,512)	(234,109)
Decrease in lease liabilities	(139,028)	(134,949)
Accrued expenses and other current liabilities	(901,101)	242,424
Net cash used in operating activities	(3,260,551)	(2,799,112)
Cash flows from investing activities:
Purchase of fixed assets	(766)
Net cash used in investing activities	(766)
Cash flows from financing activities
Net proceeds from issuance of common stock and investment option		5,153,090
Net proceeds from issuance of preferred stock		4,022,700
Preferred stock dividend	(492,572)
Proceeds from exercise of stock options		78,000
Net cash from (used in) financing activities	(492,572)	9,253,790
Net increase (decrease) in cash and cash equivalents	(3,753,889)	6,454,678
Cash and cash equivalents at beginning of period	6,769,603	10,003,375
Cash and cash equivalents at end of period	3,015,714	16,458,053
Supplemental disclosure of Cash Flow Information:
Conversion of Series C Preferred Stock to Common Stock	$ 2,679,019